Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Neupro receives approvable letter for early Parkinson's disease

March 6, 2006

Nonapprovable letter for Emezine

March 6, 2006

Medivation updates progress of Dimebon for Alzheimer's and Huntington's disease

March 3, 2006

Memory completes discovery work in PDE4 inhibitor collaboration with Roche

March 2, 2006

Memory and Roche amend nicotinic alpha-7 agonist agreement

March 2, 2006

Novel potential antiemetics emerge from Merck Sharp and Dohme

March 2, 2006

Pfizer's novel SSRI chosen as a clinical candidate

March 2, 2006

Compounds with potential applicability in neurological disorders patented

March 1, 2006

Emsam approved for major depressive disorder

March 1, 2006

New phase I study for NGX-267 for Alzheimer's disease

March 1, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...